Funding Rounds
AgomAb Therapeutics Series C (2023, $100M)
AgomAb TherapeuticsDrug discovery platform for fibrotic diseases.
Summary
Stage: Series C
Raised Amount: $100.66M
Raised Date: 2023-11-01
Stage: Series C
Raised Amount: $100.66M
Raised Date: 2023-11-01